Latest Regulatory Milestones News

Australian Oil Company Limited (ASX: AOK) has completed a second crude oil lifting from its Emu Apple Oil Field and identified fresh exploration anomalies in the Surat Basin, while progressing development plans and commercial negotiations for its Riverslea and Major Gas Fields.

Vault Minerals has submitted a fully certified Closure Plan Amendment for its Southern Tailings Management Facility, marking a regulatory milestone that supports a planned restart of underground development in Q1 FY27 and gold production in Q1 FY28 at Sugar Zone, Ontario.

TruScreen has secured clinical validation from the world’s largest cervical screening study in China, setting the stage for rapid market expansion across Asia, Africa, and Europe.

CleanSpace Holdings has achieved a major regulatory milestone with European EN 12941 certification for its new AGILE loose-fitting PAPR, positioning the company for growth in its largest market and preparing for imminent Australian approval.

Island Pharmaceuticals is accelerating development of its broad-spectrum antiviral Galidesivir, progressing clinical, regulatory, and manufacturing milestones under the FDA Animal Rule pathway with expanded USAMRIID collaboration and biodefence positioning.

Imricor Medical Systems has submitted the third of four Premarket Approval modules to the FDA, marking a key step towards US approval of its MR-guided cardiac ablation devices.

Cokal Limited has secured regulatory approval to resume mining at its Bumi Barito Mineral project, with operations set to restart mid-June and a 10,000 MT coal shipment planned for late June.

Sentinel Metals has kicked off its first diamond drilling campaign at the Columbia Gold-Silver Project in Montana, marking a major regulatory milestone and deploying a low-emission rig to test high-priority targets.

TechGen Metals has cleared the final regulatory hurdle to begin maiden diamond drilling at its Blue Devil Project in WA, targeting large-scale copper-gold systems with government co-funding easing exploration costs.

Alterity Therapeutics has clinched FDA agreement on the pivotal Phase 3 trial design for ATH434, targeting Multiple System Atrophy, with the trial set to begin by the end of 2026.

Findi Limited has transitioned Stephen Benton to Non-Executive Chairman while Nicholas Smedley refocuses on the Indian business and TSI IPO plans. A strategic review aims to sharpen capital allocation and progress the Payments Bank licence.

Ardea Resources' Kalgoorlie Nickel Project – Goongarrie Hub has been awarded Lead Agency Status by the Western Australian Government, marking a key regulatory milestone that underscores its strategic importance in the critical minerals sector.